tiprankstipranks
Entero Therapeutics Executive Team Strategic Reshuffle
Company Announcements

Entero Therapeutics Executive Team Strategic Reshuffle

Pick the best stocks and maximize your portfolio:

Entero Therapeutics (ENTO) just unveiled an announcement.

Entero Therapeutics, Inc. has announced a strategic shift in their executive team, with Dr. Jack Syage transitioning from Chief Operating Officer to Chief Scientific Officer, while maintaining his role as President. This move, effective immediately, comes without changes to his compensation and signifies a realignment of leadership roles within the company to better leverage Dr. Syage’s expertise.

Learn more about ENTO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyEntero Therapeutics announces proposed reverse merger with Journey Therapeutics
TipRanks Auto-Generated NewsdeskEntero Therapeutics Strikes Deal for Drug Trial Compliance Tech
TheFlyEntero Therapeutics signs letter of intent with Data Vault Holdings
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App